Idera Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, has named Joanna Horobin, senior vice president and chief medical officer. Dr. Horobin was most recently the chief medical officer of Verastem Inc. and previously served as chief executive officer of Syndax Pharmaceuticals. “After an extensive search process, I am thrilled that we are able to bring Joanna into Idera, where her im...